CDK2 and ovarian carcinoma: Another study regarding osthole and its anticancer potential on different ovarian cancer cell lines (A2780 and OV2008) was carried out by Jiang et al. They reported that osthole treatment on these cells caused the inhibition of protein expressions of cyclin B1 and CDK2.